Literature DB >> 19697135

Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center.

Jackson A Gondim1, Michele Schops, João Paulo C de Almeida, Lucas Alverne F de Albuquerque, Erika Gomes, Tânia Ferraz, Francisca Andréa C Barroso.   

Abstract

Pituitary tumors are challenging tumors in the sellar region. Surgical approaches to the pituitary have undergone numerous refinements over the last 100 years. The introduction of the endoscope have revolutionized pituitary surgery. The aim of this study is to report the results of a consecutive series of patients undergoing pituitary surgery using a pure endoscopic endonasal approach and to evaluate the efficacy and safety of this procedure. We reviewed the data of 228 consecutive patients who underwent endonasal transsphenoidal adenoma removal over an 10-year period. Pre- and post-operative hormonal status (at least 3 months after surgery) were analyzed and compared with clinical parameters presented by the patients. Tumor removal rate, endocrinological outcomes, and complications were retrospectively assessed in 228 patients with pituitary adenomas who underwent 251 procedures between December 1998 and December 2007. There were 93 nonfunctioning adenomas, 58 growth hormone-secreting, 41 prolactin-secreting, 28 adrenocorticotropin hormone secreting, 7 FSH-LH secreting and 1 thyroid-stimulating hormone-secreting adenomas. Gross total removal was achieved in 79.3% of the cases after a median follow-up of 61.5 months. The remission results for patients with nonfunctioning adenomas was 83% and for functioning adenomas were 76.3% (70.6% for GH hormone-secreting, 85.3% for prolactin hormone-secreting, 71.4% for ACTH hormone-secreting, 85.7% for FSH-LH hormone-secreting and 100% for TSH hormone-secreting), with no recurrence at the time of the last follow-up. Post-operative complications were present in 35 (13.9%) cases. The most frequent complications were temporary and permanent diabetes insipidus (six and two cases, respectively), syndrome of inappropriate antidiuretic hormone secretion (two cases) and CSF leaks (eight cases). There was no death related to the procedure in this series. The endoscopic endonasal approach for resection of pituitary adenomas, provides acceptable results representing a safe alternative procedure to the microscopic approach. This less invasive method, associated with a small number of complications, provides excellent tumor removal rates and represents an important tool for the achievement of good results in the pituitary surgery, mainly for the complete removal of large adenomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19697135     DOI: 10.1007/s11102-009-0195-x

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  40 in total

Review 1.  Endoscopy and transsphenoidal surgery.

Authors:  Paolo Cappabianca; Enrico de Divitiis
Journal:  Neurosurgery       Date:  2004-05       Impact factor: 4.654

2.  Endoscopic endonasal transsphenoidal surgery.

Authors:  Paolo Cappabianca; Luigi Maria Cavallo; Enrico de Divitiis
Journal:  Neurosurgery       Date:  2004-10       Impact factor: 4.654

3.  Consensus statement: medical management of acromegaly.

Authors:  S Melmed; F Casanueva; F Cavagnini; P Chanson; L A Frohman; R Gaillard; E Ghigo; K Ho; P Jaquet; D Kleinberg; S Lamberts; E Laws; G Lombardi; M C Sheppard; M Thorner; M L Vance; J A H Wass; A Giustina
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

4.  Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery.

Authors:  M S Kabil; J B Eby; H K Shahinian
Journal:  Minim Invasive Neurosurg       Date:  2005-12

5.  Endoscopic endonasal transsphenoidal surgery for pituitary tumors.

Authors:  C C Shen; Y C Wang; W S Hua; C S Chang; M H Sun
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2000-04

6.  A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap.

Authors:  Gustavo Hadad; Luis Bassagasteguy; Ricardo L Carrau; Juan C Mataza; Amin Kassam; Carl H Snyderman; Arlan Mintz
Journal:  Laryngoscope       Date:  2006-10       Impact factor: 3.325

7.  [Transnasal endoscopic surgery of the sellar region: study of the first 100 cases].

Authors:  Jackson Gondim; Michele Schops; Oswaldo I Tella
Journal:  Arq Neuropsiquiatr       Date:  2003-10-28       Impact factor: 1.420

8.  Transsphenoidal approach to the sella: the Johns Hopkins experience.

Authors:  D W Kennedy; E S Cohn; I D Papel; M J Holliday
Journal:  Laryngoscope       Date:  1984-08       Impact factor: 3.325

9.  Endonasal transsphenoidal pituitary surgery: is tumor volume a key factor in determining outcome?

Authors:  Amit Kumar Jain; Ashok Kumar Gupta; Ashis Pathak; Anil Bhansali; J Rajiv Bapuraj
Journal:  Am J Otolaryngol       Date:  2008 Jan-Feb       Impact factor: 1.808

10.  Results of surgical treatment for growth hormone-secreting pituitary adenomas.

Authors:  D H Davis; E R Laws; D M Ilstrup; J K Speed; M Caruso; E G Shaw; C F Abboud; B W Scheithauer; L M Root; C Schleck
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

View more
  40 in total

1.  Immediate and delayed postoperative morbidity in functional and non-functioning pituitary adenomas.

Authors:  Anna Aulinas; Cristina Colom; Juan Ybarra; Fernando Muñoz; Pere Tresserras; Eugenia Resmini; Susan M Webb
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

2.  Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients.

Authors:  Jackson A Gondim; Joao Paulo C Almeida; Lucas Alverne F Albuquerque; Michele Schops; Erika Gomes; Tania Ferraz; Wladia Sobreira; Meissa T Kretzmann
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

3.  Elevated body mass index and risk of postoperative CSF leak following transsphenoidal surgery.

Authors:  Brian J Dlouhy; Karthik Madhavan; John D Clinger; Ambur Reddy; Jeffrey D Dawson; Erin K O'Brien; Eugene Chang; Scott M Graham; Jeremy D W Greenlee
Journal:  J Neurosurg       Date:  2012-03-23       Impact factor: 5.115

4.  The use of image-guidance during transsphenoidal pituitary surgery in the United States.

Authors:  Thomas K Chung; Kristen O Riley; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2015 May-Jun       Impact factor: 2.467

Review 5.  The experience with transsphenoidal surgery and its importance to outcomes.

Authors:  Jürgen Honegger; Florian Grimm
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

6.  Predictive Factors, 30-Day Clinical Outcomes, and Costs Associated with Cerebrospinal Fluid Leak in Pituitary Adenoma Resection.

Authors:  Adish Parikh; Arjun Adapa; Stephen E Sullivan; Erin L McKean
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-18

7.  Endoscopic endonasal transsphenoidal surgery for treating pituitary adenoma via a sub-septum mucosa approach.

Authors:  Sheng Nie; Keqin Li; Yi Huang; Jikuang Zhao; Xiang Gao; Jie Sun
Journal:  Int J Clin Exp Med       Date:  2015-04-15

8.  Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients.

Authors:  Alessandro Paluzzi; Juan C Fernandez-Miranda; S Tonya Stefko; Sue Challinor; Carl H Snyderman; Paul A Gardner
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 9.  Contemporary neurosurgical techniques for pituitary tumor resection.

Authors:  John Y K Lee; Leif-Erik Bohman; Marvin Bergsneider
Journal:  J Neurooncol       Date:  2013-11-22       Impact factor: 4.130

10.  Endoscopic subperichondrial transseptal transsphenoidal approach is safe and efficient for non-extended pituitary surgery.

Authors:  Valentin Favier; Marine Le Corre; François Segnarbieux; Valérie Rigau; Isabelle Raingeard; César Cartier; Louis Crampette; Julien Boetto
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-20       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.